Physician profile
Michael Shanks
NPI 1619241783
$14,840.80
in general payments reported to CMS, 2019-2025
32 companies · $2,182 in 2025
The $2,182 reported for 2025 was more than what 82% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,064 · 2020: $302 · 2021: $1,771 · 2022: $1,569 · 2023: $2,598 · 2024: $3,355 · 2025: $2,182.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,316 · Food and Beverage: $3,184 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,600 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,315.72 |
| Food and Beverage | $3,184.03 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,600.00 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $5,060.11 | 2019-2025 | Lumenis Pulse 120h, Rezum Generator, Spaceoar System |
| Axonics, INC. | $4,283.30 | 2021-2024 | Axonics, Bulkamid |
| Neotract INC. | $2,217.19 | 2019 | |
| Endo Pharmaceuticals INC. | $533.49 | 2019-2024 | Xiaflex, Aveed, Edex |
| Antares Pharma, INC. | $408.80 | 2021-2025 | Xyosted, Tlando, Nocdurna |
| Astellas Pharma US INC | $326.41 | 2019-2025 | Xtandi |
| Janssen Biotech, INC. | $292.47 | 2023-2025 | Erleada |
| Ethicon US, LLC | $213.04 | 2019 | |
| Stryker Corporation | $190.03 | 2020-2021 | |
| Endo USA, INC. | $153.31 | 2024-2025 | Xiaflex, Aveed, Edex |
| Abbvie INC. | $144.31 | 2019-2025 | Lupron Depot |
| Sumitomo Pharma America, INC. | $130.35 | 2023-2025 | Gemtesa, Orgovyx |
| Genzyme Corporation | $123.52 | 2019-2020 | |
| Pfizer INC. | $121.13 | 2020-2025 | |
| Zyla Life Sciences, INC. | $78.41 | 2019-2020 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $55.67 | 2023-2025 | Imfinzi, Lynparza |
| Olympus America INC. | $53.63 | 2024-2025 | Itind System |
| 180 Medical, INC. | $48.23 | 2024-2025 | Gentlecath Glide |
| Bayer Healthcare Pharmaceuticals INC. | $48.22 | 2019-2021 | |
| Tolmar, INC. | $43.02 | 2023 | |
| Myriad Genetic Laboratories, INC. | $42.74 | 2025 | Prolaris |
| Merck Sharp & Dohme LLC | $40.92 | 2022-2025 | Keytruda |
| Hollister Incorporated | $38.72 | 2020 | |
| Teleflex LLC | $31.35 | 2021-2022 | |
| Allergan, INC. | $29.57 | 2019-2020 | |
| Procept Biorobotics Corporation | $29.56 | 2024 | Aquabeam System |
| Sun Pharmaceutical Industries INC. | $21.34 | 2022 | |
| Laborie Medical Technologies Corp. | $19.99 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Urogen Pharma, INC. | $19.16 | 2021 | |
| Halozyme INC | $14.91 | 2023 | |
| Ethicon INC. | $14.55 | 2021 | |
| Coloplast Corp | $13.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Shanks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.